Seer Launches Sample Study to Develop AI-Driven Cancer Diagnostics for Young Adults

On June 1, Seer Inc. (NASDAQ:SEER) announced a significant population-level study in collaboration with Korea University. This 3-year study, which is funded by the Republic of Korea’s K-Health MIRAE initiative, aims to identify novel blood-based biomarkers for early cancer diagnostics in young adults aged 20 to 30.

Seer Launches Sample Study to Develop AI-Driven Cancer Diagnostics for Young Adults

Close up of a chemist in a lab coat holding a beaker, surrounded by sophisticated life science equipment.

This initiative is the first large-scale plasma proteomics study to use mass spectrometry and AI-driven analytics for cancer detection. It will utilize Seer’s newly launched Proteograph ONE Assay and SP200 Automation Instrument, alongside the Thermo Scientific Orbitrap Astral mass spectrometer. This platform will allow for a deep and unbiased proteomic analysis of 20,000 plasma samples, which includes 15,000 from cancer patients and 5,000 from healthy controls.

Seer’s latest platform advances enable the processing of 1,000+ samples per week per instrument and require only a single mass spectrometry injection per sample, completing 80-sample batches in under 5 hours of automated runtime. This technology is expected to identify up to 10x more proteins than conventional mass spectrometry methods, which would accelerate analysis and reduce the cost and time associated with such large-scale studies. The Proteograph ONE workflow was also introduced at the 2025 American Society for Mass Spectrometry/ASMS Conference in Baltimore, MD.

Seer Inc. (NASDAQ:SEER) is a life sciences company that develops and commercializes products to decode the biology of the proteome. It markets and sells its products for research use only.

While we acknowledge the potential of SEER to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than SEER and that has 100x upside potential, check out our report about the cheapest AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.